Skip to main content
RecallsAboutBlog

Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc.: 3 recalls listed since April 2026 across FDA.

By year

  • 20263

By agency

  • FDA3

By category

  • Drug3

All recalls (3)

Hikma Abirtega (Abiraterone Acetate) Tablets

Abirtega (abiraterone acetate) USP tablets failed weight uniformity specifications.

Moderate risk, FDA, , Quality testing problem

Exelan Pharmaceuticals Ramipril Capsules USP

Ramipril Capsules USP, 10 mg, failed impurity specifications.

Moderate risk, FDA, , Drug impurity

Hikma Pharmaceuticals Alendronate Sodium Oral Solution

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Moderate risk, FDA, , Quality testing problem
Embed this list